Metformin Treatment Represses Vascular Endothelial Growth Factor Gene Transcription in MCF-7 Breast Cancer Cells

Journal Title: Open Access Journal of Oncology and Medicine - Year 2018, Vol 1, Issue 3

Abstract

Background/Aim:Targeting angiogenesis preferentially in cancer is a promising approach to improve treatment efficacy and safety. The aim of this study is investigate potential upregulation of Krüppel like factor-4(KLF-4) by inhibition of mammalian target of rapamycin (mTOR) to repress vascular endothelial growth factor (VEGF) expression in breast cancer cells. Materials and Methods: Using Western blot; bandshift assay; and Chloramphenicol acetyltransferase assay, we assessed the effect of different mTOR inhibitors on the level of mTOR pathway proteins and on KLF-4/ serum amyloid activating factor (SAF-1) SAF-1 DNA binding and consequently VEGF gene expression in MCF-7breast cancer cells. Results: mTOR inhibition increased KLF-4 level in breast cancer cells, but this inhibition, except for metformin, elicited rebound upregulation of mTOR signaling proteins. Thus metformin produced a sustained increase in KLF-4 level and concomitant disruption of SAF-1 binding to VEGF promoter with consequent inhibition of VEGF expression. Conclusion:Repurposing metformin as a potential neoadjuvant and antiangiogenic treatment could provide the basis for more effective and safer antiangiogenic treatment.

Authors and Affiliations

Mohamed Alalem, Bimal K Ray

Keywords

Related Articles

Acute Erythroblastic Leukemia Revealed by Dermatological Manifestations

Acute erythroblastic leukemia is characterized by the proliferation of a predominant erythrocyte population on other lineages. Cutaneous manifestations remain rare and misleading, making the diagnosis of difficult to sus...

Main Components of Liquid Biopsy are Greater than it Seems?

Long time ago it was wrongly thought that tumor genes and cells are only existence in the exact tumor site. In spite of the fact of the hypothesis that circulating tumor cells (CTCs) are a fundamental prerequisite to met...

Hydrogen Peroxide and Cancer

I’ll share an antidotal observation that may prove useful to cancer researchers. I studied hyper-ferritism and Ferric Chloride to see its possible link to schizophrenia. Those results are well published [1,2]. However, I...

Librarians who Request for Reprints Including those in Oncology

A 13-year retrospective study of reprint requestors was undertaken with special reference to those from research libraries. It was found that 2.8 percent of the total 2,053 requests were from such librarians. They prepon...

Immunotherapy in Some Types of Tumors

Immunotherapy exerts its antitumor action by stimulating the response immune response of patients to cancer, unlike classic treatments, which directly attack the tumor. Previously immunotherapy was limited to patients in...

Download PDF file
  • EP ID EP586783
  • DOI 10.32474/OAJOM.2018.01.000115
  • Views 93
  • Downloads 0

How To Cite

Mohamed Alalem, Bimal K Ray (2018). Metformin Treatment Represses Vascular Endothelial Growth Factor Gene Transcription in MCF-7 Breast Cancer Cells. Open Access Journal of Oncology and Medicine, 1(3), 61-67. https://europub.co.uk/articles/-A-586783